
ZURICH/GDANSK, Feb 5 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday:
ROCHE HOLDING AG ROG.S
FDA approves Roche's Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness.
COMPANY STATEMENTS
DORMAKABA HOLDING AG DOKA.S
Dormakaba expects net sales and adjusted EBITDA margin to be in line with 2024/25 FY guidance.
ECONOMY
No major Swiss economic data scheduled.
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS